Carol Hu, MD
Infectious Disease · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 6
- 3 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
6 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hu’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
6 of 6 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$7,865
Medicare paid this office $7,865 for 25 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 24 | $6,106 | $80 |
| Long return visit (40+ min) | 11 | $1,311 | $101 |
Who their Medicare patients are
25 Original Medicare patients in 2024. Average age 63 · Health risk score 1.51. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 60%.
The office billed $74,290, Medicare allowed $11,119 and paid $7,865; for 96 services of 6 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 25 | 96 | 63 | 1.51 | $74,290 | $7,865 |
| 2023 | 25 | 81 | 63 | 1.44 | $60,690 | $6,040 |
| 2022 | 21 | 89 | 64 | 1.23 | $49,654 | $6,123 |
| 2021 | 16 | 63 | 62 | 1.26 | $37,644 | $5,048 |
| 2020 | 22 | 49 | 63 | 1.75 | $25,435 | $2,804 |
| 2019 | 24 | 61 | 60 | 2.02 | $41,343 | $3,958 |
| 2018 | 21 | 50 | 61 | 1.77 | $32,025 | $3,473 |
| 2017 | 22 | 61 | 54 | 1.77 | $36,863 | $3,723 |
| 2016 | 22 | 31 | 53 | 1.56 | $15,222 | $2,000 |
| 2013 | 152 | 196 | 69 | 3.16 | $26,010 | $13,455 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Return visit (30+ min) | 24 | $4,714 | $73 |
2022: 2 services
| Return visit (30+ min) | 18 | $3,796 | $79 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $904 | $50 |
2021: 2 services
| Return visit (30+ min) | 13 | $2,247 | $77 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,545 | $86 |
2020: 1 service
| Return visit (30+ min) | 16 | $1,175 | $53 |
2019: 1 service
| Return visit (30+ min) | 24 | $3,412 | $62 |
2018: 1 service
| Return visit (30+ min) | 21 | $3,320 | $71 |
2017: 1 service
| Return visit (30+ min) | 21 | $3,478 | $60 |
2016: 1 service
| Return visit (30+ min) | 17 | $1,681 | $70 |
2013: 3 services
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 54 | $6,274 | $112 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 71 | $4,791 | $57 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 34 | $1,259 | $31 |
Medicaid work
$17,694 in 2024
Medicaid paid $17,694 for 3,035 billed services this clinician did in 2024, up to 56 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 433 | $9,575 |
| Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse transcription when performed | 201 | $4,718 |
| T cells; absolute CD4 and CD8 count, including ratio | 61 | $748 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 82 | $589 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 82 | $584 |
| T CELLS TOTAL COUNT | 61 | $557 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 177 | $342 |
| TREPONEMA PALLIDUM | 87 | $302 |
| HEPATIC FUNCTION PANEL | 162 | $275 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 13 | $4 |
| Measurement of vitamin D in serum | 17 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 29 | $0 |
| 2024 | 3,035 | 24 | 56 | $17,694 |
| 2023 | 1,907 | 17 | 42 | $7,200 |
| 2022 | 764 | 9 | 28 | $5,289 |
| 2021 | 335 | 6 | 27 | $2,817 |
| 2020 | 183 | 8 | 27 | $1,219 |
| 2019 | 364 | 10 | 21 | $2,402 |
| 2018 | 273 | 6 | 28 | $1,831 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 363 | $3,084 |
| Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse transcription when performed | 201 | $2,216 |
| T cells; absolute CD4 and CD8 count, including ratio | 80 | $539 |
| T CELLS TOTAL COUNT | 80 | $365 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 59 | $251 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 59 | $251 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 193 | $198 |
| HEPATIC FUNCTION PANEL | 184 | $183 |
| TREPONEMA PALLIDUM | 40 | $64 |
| ELECTROLYTE PANEL | 136 | $14 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 26 | $11 |
| Creatinine; blood | 136 | $10 |
2022
| Return visit (30+ min) | 298 | $4,020 |
| Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse transcription when performed | 92 | $1,116 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 69 | $68 |
| HEPATIC FUNCTION PANEL | 63 | $55 |
| ELECTROLYTE PANEL | 57 | $11 |
| Creatinine; blood | 58 | $8 |
| Blood glucose (sugar) level | 58 | $6 |
| Urea nitrogen; quantitative | 57 | $6 |
| Measurement of vitamin D in serum | 12 | $0 |
2021
| Return visit (30+ min) | 220 | $1,767 |
| Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse transcription when performed | 54 | $977 |
| HEPATIC FUNCTION PANEL | 15 | $31 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 16 | $30 |
| Blood glucose (sugar) level | 13 | $12 |
| Short return visit (20+ min) | 17 | $0 |
2020
| Return visit (30+ min) | 67 | $932 |
| Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse transcription when performed | 14 | $173 |
| HEPATIC FUNCTION PANEL | 27 | $55 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 27 | $35 |
| ELECTROLYTE PANEL | 12 | $8 |
| Creatinine; blood | 12 | $6 |
| Urea nitrogen; quantitative | 12 | $5 |
| Blood glucose (sugar) level | 12 | $5 |
2019
| Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse transcription when performed | 84 | $1,204 |
| Return visit (30+ min) | 80 | $787 |
| T cells; absolute CD4 and CD8 count, including ratio | 12 | $162 |
| T CELLS TOTAL COUNT | 12 | $131 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 43 | $76 |
| HEPATIC FUNCTION PANEL | 29 | $43 |
| ELECTROLYTE PANEL | 26 | $0 |
| Creatinine; blood | 26 | $0 |
| Blood glucose (sugar) level | 26 | $0 |
| Urea nitrogen; quantitative | 26 | $0 |
2018
| Return visit (30+ min) | 187 | $1,112 |
| Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse transcription when performed | 29 | $485 |
| T cells; absolute CD4 and CD8 count, including ratio | 14 | $113 |
| T CELLS TOTAL COUNT | 14 | $92 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 16 | $18 |
| HEPATIC FUNCTION PANEL | 13 | $11 |
Drugs they prescribed that Part D paid
$1,674,019
Pharmacies billed $1,674,019 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,243 generic and fewer than 11 brand-name prescriptions · $1,674,019 in drug cost · 21 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Biktarvy | 201 | $717,567 | $3,570 |
| Tivicay | 61 | $134,157 | $2,199 |
| Dovato | 43 | $124,073 | $2,885 |
| Symtuza | 24 | $116,231 | $4,843 |
| Cabenuva | 16 | $107,701 | $6,731 |
See all 61 drugs
| Biktarvy | 201 | $717,567 | $3,570 |
| Tivicay | 61 | $134,157 | $2,199 |
| Dovato | 43 | $124,073 | $2,885 |
| Symtuza | 24 | $116,231 | $4,843 |
| Cabenuva | 16 | $107,701 | $6,731 |
| Pifeltro | 52 | $87,704 | $1,687 |
| Juluca | 19 | $60,290 | $3,173 |
| Isentress | 32 | $57,736 | $1,804 |
| Descovy | 26 | $56,619 | $2,178 |
| Odefsey | 13 | $44,254 | $3,404 |
| Triumeq | 12 | $40,153 | $3,346 |
| Prezista | 18 | $34,061 | $1,892 |
| Ozempic | 18 | $16,755 | $931 |
| Norvir | 11 | $5,004 | $455 |
| Incruse Ellipta | 12 | $3,706 | $309 |
| Dulera | 11 | $3,287 | $299 |
| Fluconazole | 15 | $835 | $56 |
| Lamivudine | 12 | $585 | $49 |
| Famotidine | 53 | $468 | $9 |
| Atorvastatin | 173 | $402 | $2 |
| Albuterol Sulfate Hfa | 13 | $367 | $28 |
| Quetiapine | 29 | $310 | $11 |
| Baclofen | 13 | $270 | $21 |
| Bupropion Xl | 15 | $267 | $18 |
| Fosinopril | 24 | $237 | $10 |
| Emtricitabine-Tenofovir Disop | 12 | $234 | $19 |
| Omeprazole | 31 | $220 | $7 |
| Midodrine | 22 | $195 | $9 |
| Pregabalin | 11 | $177 | $16 |
| Tamsulosin | 39 | $170 | $4 |
| Acyclovir | 11 | $161 | $15 |
| Losartan | 34 | $132 | $4 |
| Diclofenac | 11 | $123 | $11 |
| Pantoprazole | 18 | $122 | $7 |
| Gabapentin | 49 | $118 | $2 |
| Fludrocortisone Acetate | 20 | $111 | $6 |
| Amlodipine Besylate | 68 | $106 | $2 |
| Fluticasone Propionate | 15 | $102 | $7 |
| Rosuvastatin | 29 | $100 | $3 |
| Hydrocortisone | 30 | $98 | $3 |
| Montelukast | 12 | $89 | $7 |
| Amiloride | 13 | $80 | $6 |
| Aripiprazole | 11 | $79 | $7 |
| Benazepril | 22 | $76 | $3 |
| Lisinopril | 22 | $74 | $3 |
| Alendronate | 28 | $72 | $3 |
| Mupirocin | 16 | $71 | $4 |
| Pravastatin | 11 | $71 | $6 |
| Triamcinolone Acetonide | 20 | $62 | $3 |
| Isosorbide Mononitrate Er | 15 | $61 | $4 |
| Levothyroxine | 11 | $60 | $5 |
| Enalapril Maleate | 12 | $56 | $5 |
| Finasteride | 12 | $47 | $4 |
| Hydrochlorothiazide | 38 | $44 | $1 |
| Furosemide | 30 | $44 | $1 |
| Metformin | 15 | $32 | $2 |
| Fluoxetine | 11 | $26 | $2 |
| Ondansetron | 19 | $25 | $1 |
| Trazodone | 14 | $17 | $1 |
| Carvedilol | 13 | $12 | $1 |
| Zolpidem | 12 | $10 | $1 |
Year by year
| 2024 | 1,879 | 43 | None | None | $1,674,019 |
| 2023 | 1,778 | 46 | None | None | $1,788,711 |
| 2022 | 1,292 | 36 | None | None | $1,250,932 |
| 2021 | 999 | 29 | 0% (0) | 42% | $898,792 |
| 2020 | 944 | 31 | 0% (0) | None | $869,309 |
| 2019 | 823 | 32 | None | None | $600,502 |
| 2018 | 304 | 20 | None | 34% | $148,892 |
| 2017 | 499 | 31 | 5% (24) | None | $271,446 |
| 2016 | 777 | 68 | 3% (25) | 52% | $484,325 |
| 2015 | 288 | 38 | None | None | $139,165 |
| 2014 | 55 | None | None | 65% | $52,449 |
| 2013 | 40 | 12 | 0% (0) | 75% | $33,438 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 57 drugs
| Biktarvy | 187 | $706,348 | $3,777 |
| Triumeq | 39 | $131,875 | $3,381 |
| Cabenuva | 19 | $121,624 | $6,401 |
| Symtuza | 24 | $111,227 | $4,634 |
| Dovato | 34 | $100,214 | $2,947 |
| Juluca | 26 | $89,258 | $3,433 |
| Tivicay | 36 | $79,025 | $2,195 |
| Isentress | 39 | $78,350 | $2,009 |
| Odefsey | 20 | $75,310 | $3,766 |
| Pifeltro | 40 | $72,328 | $1,808 |
| Prezista | 25 | $57,756 | $2,310 |
| Descovy | 25 | $57,285 | $2,291 |
| Edurant | 12 | $17,500 | $1,458 |
| Spiriva Handihaler | 17 | $7,830 | $461 |
| Norvir | 13 | $7,541 | $580 |
| Janumet | 12 | $7,149 | $596 |
| Advair Diskus | 11 | $5,303 | $482 |
| Symbicort | 11 | $2,969 | $270 |
| Ritonavir | 12 | $2,667 | $222 |
| Fluconazole | 22 | $1,896 | $86 |
| Atorvastatin | 194 | $1,885 | $10 |
| Aripiprazole | 17 | $1,380 | $81 |
| Rosuvastatin | 18 | $703 | $39 |
| Levetiracetam | 13 | $628 | $48 |
| Amlodipine Besylate | 58 | $620 | $11 |
| Ventolin Hfa | 13 | $608 | $47 |
| Tamsulosin | 47 | $591 | $13 |
| Albuterol Sulfate Hfa | 13 | $573 | $44 |
| Pantoprazole | 15 | $528 | $35 |
| Omeprazole | 25 | $522 | $21 |
| Losartan | 33 | $492 | $15 |
| Emtricitabine-Tenofovir Disop | 14 | $420 | $30 |
| Quetiapine | 12 | $371 | $31 |
| Fosinopril | 24 | $343 | $14 |
| Diclofenac | 11 | $319 | $29 |
| Lamotrigine | 19 | $308 | $16 |
| Midodrine | 16 | $302 | $19 |
| Famotidine | 19 | $258 | $14 |
| Finasteride | 18 | $251 | $14 |
| Escitalopram | 15 | $244 | $16 |
| Enalapril Maleate | 11 | $243 | $22 |
| Ketoconazole | 16 | $238 | $15 |
| Losartan-Hydrochlorothiazide | 13 | $221 | $17 |
| Cilostazol | 11 | $201 | $18 |
| Alendronate | 49 | $193 | $4 |
| Zolpidem | 12 | $186 | $16 |
| Mirtazapine | 12 | $184 | $15 |
| Lisinopril | 19 | $142 | $7 |
| Benazepril | 13 | $117 | $9 |
| Levothyroxine | 14 | $100 | $7 |
| Fluoxetine | 13 | $87 | $7 |
| Gabapentin | 19 | $72 | $4 |
| Hydrocortisone | 11 | $63 | $6 |
| Hydrochlorothiazide | 33 | $58 | $2 |
| Triamcinolone Acetonide | 11 | $39 | $4 |
| Furosemide | 13 | $36 | $3 |
| Metformin | 14 | $31 | $2 |
2022: 42 drugs
| Biktarvy | 132 | $488,303 | $3,699 |
| Cabenuva | 25 | $106,064 | $4,243 |
| Symtuza | 22 | $95,720 | $4,351 |
| Triumeq | 25 | $85,212 | $3,408 |
| Odefsey | 30 | $80,470 | $2,682 |
| Isentress | 32 | $59,629 | $1,863 |
| Tivicay | 27 | $55,016 | $2,038 |
| Descovy | 24 | $53,146 | $2,214 |
| Dovato | 19 | $44,429 | $2,338 |
| Prezista | 18 | $37,735 | $2,096 |
| Juluca | 12 | $36,464 | $3,039 |
| Pifeltro | 15 | $25,990 | $1,733 |
| Edurant | 12 | $16,668 | $1,389 |
| Janumet | 13 | $5,754 | $443 |
| Spiriva Handihaler | 16 | $5,492 | $343 |
| Symbicort | 14 | $3,670 | $262 |
| Ritonavir | 15 | $2,837 | $189 |
| Mitigare | 12 | $1,581 | $132 |
| Atorvastatin | 174 | $1,088 | $6 |
| Emtricitabine-Tenofovir Disop | 14 | $508 | $36 |
| Quetiapine | 23 | $456 | $20 |
| Amlodipine Besylate | 46 | $277 | $6 |
| Tamsulosin | 30 | $267 | $9 |
| Isosorbide Dinitrate | 13 | $227 | $17 |
| Omeprazole | 22 | $215 | $10 |
| Zolpidem | 12 | $208 | $17 |
| Benazepril | 27 | $202 | $7 |
| Finasteride | 25 | $191 | $8 |
| Fosinopril | 14 | $172 | $12 |
| Alendronate | 39 | $149 | $4 |
| Labetalol | 13 | $133 | $10 |
| Cilostazol | 11 | $105 | $10 |
| Hydralazine | 14 | $104 | $7 |
| Amiloride | 13 | $103 | $8 |
| Escitalopram | 15 | $99 | $7 |
| Nortriptyline | 12 | $86 | $7 |
| Losartan | 11 | $84 | $8 |
| Famotidine | 12 | $66 | $6 |
| Fluoxetine | 13 | $62 | $5 |
| Hydrochlorothiazide | 22 | $43 | $2 |
| Lisinopril | 12 | $33 | $3 |
| Gabapentin | 11 | $28 | $3 |
2021: 33 drugs
| Biktarvy | 126 | $420,050 | $3,334 |
| Odefsey | 33 | $85,145 | $2,580 |
| Tivicay | 28 | $54,214 | $1,936 |
| Descovy | 23 | $47,760 | $2,077 |
| Symtuza | 12 | $47,191 | $3,933 |
| Dovato | 15 | $37,470 | $2,498 |
| Juluca | 12 | $34,747 | $2,896 |
| Triumeq | 11 | $34,631 | $3,148 |
| Isentress | 16 | $27,405 | $1,713 |
| Pifeltro | 15 | $24,080 | $1,605 |
| Jentadueto Xr | 12 | $5,663 | $472 |
| Spiriva | 14 | $4,622 | $330 |
| Janumet | 13 | $4,460 | $343 |
| Atorvastatin | 145 | $1,102 | $8 |
| Ventolin Hfa | 14 | $803 | $57 |
| Pantoprazole | 12 | $231 | $19 |
| Labetalol | 11 | $211 | $19 |
| Tamsulosin | 18 | $195 | $11 |
| Fosinopril | 14 | $173 | $12 |
| Alendronate | 39 | $149 | $4 |
| Finasteride | 13 | $148 | $11 |
| Losartan-Hydrochlorothiazide | 14 | $147 | $11 |
| Amlodipine Besylate | 34 | $126 | $4 |
| Zolpidem | 13 | $115 | $9 |
| Cilostazol | 13 | $87 | $7 |
| Benazepril | 16 | $74 | $5 |
| Omeprazole | 11 | $65 | $6 |
| Escitalopram | 12 | $57 | $5 |
| Fluoxetine | 13 | $51 | $4 |
| Gabapentin | 12 | $48 | $4 |
| Glipizide | 12 | $48 | $4 |
| Lisinopril | 18 | $45 | $3 |
| Hydrochlorothiazide | 13 | $26 | $2 |
2020: 30 drugs
| Biktarvy | 123 | $382,515 | $3,110 |
| Tivicay | 39 | $72,130 | $1,849 |
| Odefsey | 25 | $65,881 | $2,635 |
| Genvoya | 17 | $54,895 | $3,229 |
| Symtuza | 14 | $53,207 | $3,800 |
| Descovy | 25 | $48,510 | $1,940 |
| Pifeltro | 25 | $37,572 | $1,503 |
| Juluca | 13 | $35,871 | $2,759 |
| Dovato | 14 | $33,134 | $2,367 |
| Jentadueto Xr | 15 | $6,652 | $443 |
| Spiriva | 13 | $4,589 | $353 |
| Janumet | 11 | $3,597 | $327 |
| Atorvastatin | 147 | $711 | $5 |
| Losartan-Hydrochlorothiazide | 12 | $547 | $46 |
| Isosorbide Dinitrate | 13 | $248 | $19 |
| Fosinopril | 14 | $177 | $13 |
| Ketoconazole | 12 | $158 | $13 |
| Labetalol | 13 | $150 | $12 |
| Amlodipine Besylate | 37 | $136 | $4 |
| Levothyroxine | 12 | $129 | $11 |
| Alendronate | 34 | $94 | $3 |
| Cilostazol | 13 | $85 | $7 |
| Furosemide | 15 | $83 | $6 |
| Finasteride | 13 | $66 | $5 |
| Escitalopram | 12 | $65 | $5 |
| Benazepril | 16 | $61 | $4 |
| Tamsulosin | 15 | $53 | $4 |
| Glipizide | 11 | $51 | $5 |
| Hydrochlorothiazide | 13 | $18 | $1 |
| Fluoxetine | 13 | $13 | $1 |
2019: 23 drugs
| Biktarvy | 67 | $204,782 | $3,056 |
| Tivicay | 45 | $78,651 | $1,748 |
| Symtuza | 16 | $58,011 | $3,626 |
| Genvoya | 18 | $54,266 | $3,015 |
| Descovy | 21 | $37,352 | $1,779 |
| Juluca | 13 | $34,613 | $2,663 |
| Pifeltro | 16 | $23,277 | $1,455 |
| Prezista | 13 | $21,360 | $1,643 |
| Jentadueto Xr | 14 | $5,880 | $420 |
| Ritonavir | 17 | $1,298 | $76 |
| Calcium Acetate | 22 | $1,158 | $53 |
| Ventolin Hfa | 18 | $1,075 | $60 |
| Atorvastatin | 106 | $649 | $6 |
| Gabapentin | 33 | $205 | $6 |
| Levothyroxine | 14 | $155 | $11 |
| Tamsulosin | 16 | $153 | $10 |
| Amlodipine Besylate | 27 | $129 | $5 |
| Ketoconazole | 12 | $123 | $10 |
| Alendronate | 30 | $93 | $3 |
| Glipizide | 14 | $85 | $6 |
| Escitalopram | 12 | $65 | $5 |
| Losartan-Hydrochlorothiazide | 12 | $54 | $4 |
| Sertraline | 11 | $39 | $4 |
2018: 5 drugs
| Triumeq | 14 | $41,404 | $2,957 |
| Tivicay | 15 | $24,127 | $1,608 |
| Atorvastatin | 28 | $165 | $6 |
| Gabapentin | 20 | $86 | $4 |
| Lisinopril | 12 | $34 | $3 |
2017: 15 drugs
| Genvoya | 27 | $72,852 | $2,698 |
| Odefsey | 13 | $33,055 | $2,543 |
| Prezista | 25 | $32,567 | $1,303 |
| Descovy | 16 | $23,309 | $1,457 |
| Isentress | 17 | $20,221 | $1,189 |
| Truvada | 11 | $13,853 | $1,259 |
| Norvir | 14 | $3,305 | $236 |
| Ventolin Hfa | 23 | $1,774 | $77 |
| Atorvastatin | 30 | $213 | $7 |
| Hydroxyzine Pamoate | 11 | $170 | $15 |
| Levothyroxine | 11 | $134 | $12 |
| Gabapentin | 18 | $79 | $4 |
| Pravastatin | 11 | $78 | $7 |
| Alendronate | 15 | $47 | $3 |
| Lisinopril | 17 | $46 | $3 |
2016: 23 drugs
| Truvada | 55 | $74,716 | $1,358 |
| Atripla | 28 | $65,536 | $2,341 |
| Genvoya | 24 | $60,346 | $2,514 |
| Prezista | 39 | $48,295 | $1,238 |
| Isentress | 31 | $38,930 | $1,256 |
| Reyataz | 21 | $28,810 | $1,372 |
| Descovy | 16 | $21,214 | $1,326 |
| Kaletra | 11 | $10,337 | $940 |
| Norvir | 36 | $9,554 | $265 |
| Lamivudine | 11 | $3,548 | $323 |
| Proair Hfa | 11 | $697 | $63 |
| Atorvastatin | 23 | $273 | $12 |
| Gabapentin | 12 | $245 | $20 |
| Levothyroxine | 14 | $181 | $13 |
| Bd Ultra-Fine Pen Needle | 12 | $166 | $14 |
| Hydrocodone-Acetaminophen | 13 | $153 | $12 |
| Spironolactone | 13 | $145 | $11 |
| Pioglitazone | 12 | $120 | $10 |
| Omeprazole | 23 | $111 | $5 |
| Escitalopram | 12 | $66 | $5 |
| Metformin | 27 | $66 | $2 |
| Alendronate | 11 | $30 | $3 |
| Lisinopril | 20 | $29 | $1 |
2015: 7 drugs
| Truvada | 18 | $23,086 | $1,283 |
| Prezista | 19 | $21,443 | $1,129 |
| Isentress | 19 | $19,320 | $1,017 |
| Reyataz | 13 | $16,493 | $1,269 |
| Norvir | 28 | $6,746 | $241 |
| Atorvastatin | 13 | $92 | $7 |
| Losartan | 15 | $40 | $3 |
Money from drug and device companies
$29 in 2023
A payment is not proof that care is biased.
| GlaxoSmithKline | Shingrix | $29 | 1 payment
|
See the published payment
| GlaxoSmithKline | Meals · 2023-11-14 | Shingrix | $29 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1124286869
- Trained
- Jefferson Medical College of Thomas Jefferson University, 2008
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X); Student in a training program (390200000X)
- Mailing address
- 2400 Moorpark Ave Ste 316, San Jose, CA, 95128
- NPI first listed
- 2008-05-29
- NPI last updated
- 2025-05-20
- NPI record certified
- 2025-05-20
This is when the NPI record was last certified, not a medical board exam.